Breast cancer-related lymphedema (BCRL) occurs in a significant number of breast cancer survivors as a consequence of the axillary lymphatics' impairment after therapy (mainly axillary surgery and irradiation). Despite the recent achievements in the clinical management of these patients, BCRL is often diagnosed at its occurrence. In most cases, it remains a progressive and irreversible condition, with dramatic consequences in terms of quality of life and on sanitary costs. There are still no validated pre-surgical strategies to identify individuals that harbor an increased risk of BCRL. However, clinical, therapeutic, and tumor-specific traits are recurrent in these patients. Over the past few years, many studies have unraveled the complexity of the molecular and transcriptional events leading to the lymphatic system ontogenesis. Additionally, molecular insights are coming from the study of the germline alterations involved at variable levels in BCRL models. Regrettably, there is a substantial lack of predictive biomarkers for BCRL, given that our knowledge of its molecular milieu remains extremely puzzled. The purposes of this review were (i) to outline the biology underpinning the ontogenesis of the lymphatic system; (ii) to assess the current state of knowledge of the molecular alterations that can be involved in BCRL pathogenesis and progression; (iii) to discuss the present and short-term future perspectives in biomarker-based patients' risk stratification; and (iv) to provide practical information that can be employed to improve the quality of life of these patients.
Integrating Biological Advances Into the Clinical Management of Breast Cancer Related Lymphedema / M. Invernizzi, G. Lopez, A. Michelotti, K. Venetis, E. Sajjadi, L. De Mattos-Arruda, M. Ghidini, L. Runza, A. de Sire, R. Boldorini, N. Fusco. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - 10(2020 Apr 02).
|Titolo:||Integrating Biological Advances Into the Clinical Management of Breast Cancer Related Lymphedema|
LOPEZ, GIANLUCA (Secondo)
FUSCO, NICOLA (Ultimo) (Corresponding)
|Parole Chiave:||breast cancer; breast cancer related lymphedema; genetics; pathobiology; quality of life; survivorship;|
|Settore Scientifico Disciplinare:||Settore MED/08 - Anatomia Patologica|
Settore MED/34 - Medicina Fisica e Riabilitativa
Settore MED/06 - Oncologia Medica
|Data di pubblicazione:||2-apr-2020|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.3389/fonc.2020.00422|
|Appare nelle tipologie:||01 - Articolo su periodico|
File in questo prodotto:
| [Front Oncol] Integrating biological advances into the clinical management of breast cancer related lymphedema.pdf||Publisher's version/PDF||Open Access Visualizza/Apri|